FMP
AngioDynamics, Inc.
ANGO
NASDAQ
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors. It also offers BioSentry tract sealant systems, IsoLoc Endorectal Balloon's, alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. In addition, the company provides endovascular therapies products in the areas of thrombus management, atherectomy, peripheral products (Core), and venous insufficiency. Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies that are used primarily to deliver short-term drug therapies, such as chemotherapeutic agents and antibiotics, into the central venous system under the BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax names. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.
9.28 USD
0.51 (5.5%)
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
264.16M
291.01M
316.22M
338.75M
303.91M
315.82M
328.19M
341.05M
354.41M
368.29M
-
10.17
8.66
7.13
-10.28
3.92
3.92
3.92
3.92
-143.74M
-8.9M
11.13M
12.19M
-14.29M
-34.77M
-36.14M
-37.55M
-39.02M
-40.55M
-54.41
-3.06
3.52
3.6
-4.7
-11.01
-11.01
-11.01
-11.01
-167.23M
-35.19M
-18.36M
-20.98M
-42M
-63.94M
-66.44M
-69.04M
-71.75M
-74.56M
-63.31
-12.09
-5.81
-6.19
-13.82
-20.24
-20.24
-20.24
-20.24
23.49M
26.29M
29.5M
33.17M
27.71M
29.16M
30.3M
31.49M
32.72M
34.01M
8.89
9.03
9.33
9.79
9.12
9.23
9.23
9.23
9.23
EBIT (Operating profit)(Operating income)(Operating earning) = GROSS MARGIN (REVENUE - COGS) - OPERATING EXPENSES (R&D, RENT) EBIT = (1*) (2*) -> operating process (leverage -> interest -> EBT -> tax -> net Income) EBITDA = GROSS MARGIN (REVENUE - COGS) - OPERATING EXPENSES (R&D, RENT) + Depreciation + amortization EBITA = (1*) (2*) (3*) (4*) company's CURRENT operating profitability (i.e., how much profit it makes with its present assets and its operations on the products it produces and sells, as well as providing a proxy for cash flow) -> performance of a company (1*) discounting the effects of interest payments from different forms of financing (by ignoring interest payments), (2*) political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill) (3*) collections of assets (by ignoring depreciation of assets) (4*) different takeover histories (by ignoring amortization often stemming from goodwill)